A Pediatric Case of Systemic Lupus Erythematosus Developed 10 Years after Cord Blood Transplantation for Juvenile Myelomonocytic Leukemia
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a most powerful immunotherapy for hematological malignancies. However, the impact of immunological disturbances as a result of allo-HSCT is not understood well. We experienced an 11-year-old boy who presented with systemic lupus eryth...
Saved in:
Main Authors: | Masayuki Nagasawa, Yuki Aoki |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Case Reports in Transplantation |
Online Access: | http://dx.doi.org/10.1155/2012/619126 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia
by: Xiaoling Liu, et al.
Published: (2012-01-01) -
Prolonged Pediatric Extracorporeal Membrane Oxygenation Support with Cardiopulmonary Failure in Juvenile Myelomonocytic Leukemia
by: Maris Bartkevics, et al.
Published: (2020-01-01) -
Neuropsychiatric Involvement in Juvenile-Onset Systemic Lupus Erythematosus
by: Mohammad-Amin Khajezadeh, et al.
Published: (2018-01-01) -
Endocrine and metabolic comorbidities in juvenile-onset systemic lupus erythematosus
by: Su Jin Park, et al.
Published: (2025-02-01) -
Chronic Myelomonocytic Leukemia following Multicentric Castleman Disease
by: Feng Li, et al.
Published: (2018-01-01)